• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

目标监测对随机对照试验数据质量和数据管理工作量的影响:一项前瞻性对比研究。

Impact of a targeted monitoring on data-quality and data-management workload of randomized controlled trials: A prospective comparative study.

机构信息

CIC 1414 (Clinical Investigation Center), INSERM, Rennes, France.

Clinical Pharmacology Department, CHU Rennes, Rennes, France.

出版信息

Br J Clin Pharmacol. 2019 Dec;85(12):2784-2792. doi: 10.1111/bcp.14108. Epub 2019 Dec 14.

DOI:10.1111/bcp.14108
PMID:31471967
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6955406/
Abstract

AIMS

Monitoring risk-based approaches in clinical trials are encouraged by regulatory guidance. However, the impact of a targeted source data verification (SDV) on data-management (DM) workload and on final data quality needs to be addressed.

METHODS

MONITORING was a prospective study aiming at comparing full SDV (100% of data verified for all patients) and targeted SDV (only key data verified for all patients) followed by the same DM program (detecting missing data and checking consistency) on final data quality, global workload and staffing costs.

RESULTS

In all, 137 008 data including 18 124 key data were collected for 126 patients from 6 clinical trials. Compared to the final database obtained using the full SDV monitoring process, the final database obtained using the targeted SDV monitoring process had a residual error rate of 1.47% (95% confidence interval, 1.41-1.53%) on overall data and 0.78% (95% confidence interval, 0.65-0.91%) on key data. There were nearly 4 times more queries per study with targeted SDV than with full SDV (mean ± standard deviation: 132 ± 101 vs 34 ± 26; P = .03). For a handling time of 15 minutes per query, the global workload of the targeted SDV monitoring strategy remained below that of the full SDV monitoring strategy. From 25 minutes per query it was above, increasing progressively to represent a 50% increase for 45 minutes per query.

CONCLUSION

Targeted SDV monitoring is accompanied by increased workload for DM, which allows to obtain a small proportion of remaining errors on key data (<1%), but may substantially increase trial costs.

摘要

目的

监管指南鼓励临床试验中采用基于风险的监测方法。然而,需要解决靶向源数据核查(SDV)对数据管理(DM)工作量和最终数据质量的影响。

方法

MONITORING 是一项前瞻性研究,旨在比较全 SDV(对所有患者的所有数据进行 100%核查)和靶向 SDV(仅对所有患者的关键数据进行核查),然后使用相同的 DM 程序(检测缺失数据和检查一致性)对最终数据质量、总体工作量和人员成本进行比较。

结果

共收集了来自 6 项临床试验的 126 名患者的 137008 份数据,包括 18124 份关键数据。与使用全 SDV 监测过程获得的最终数据库相比,使用靶向 SDV 监测过程获得的最终数据库在整体数据上的残留错误率为 1.47%(95%置信区间,1.41-1.53%),在关键数据上的残留错误率为 0.78%(95%置信区间,0.65-0.91%)。与全 SDV 相比,靶向 SDV 每个研究的查询数量几乎多了 4 倍(平均值±标准差:132±101 与 34±26;P=0.03)。对于每个查询 15 分钟的处理时间,靶向 SDV 监测策略的总体工作量仍低于全 SDV 监测策略。从 25 分钟/查询开始,它会高于全 SDV 监测策略,并逐渐增加到 45 分钟/查询时增加 50%。

结论

靶向 SDV 监测会增加 DM 的工作量,从而使关键数据上的残留错误比例(<1%)略有下降,但可能会大幅增加试验成本。

相似文献

1
Impact of a targeted monitoring on data-quality and data-management workload of randomized controlled trials: A prospective comparative study.目标监测对随机对照试验数据质量和数据管理工作量的影响:一项前瞻性对比研究。
Br J Clin Pharmacol. 2019 Dec;85(12):2784-2792. doi: 10.1111/bcp.14108. Epub 2019 Dec 14.
2
Impact of source data verification on data quality in clinical trials: an empirical post hoc analysis of three phase 3 randomized clinical trials.源数据核查对临床试验数据质量的影响:三项III期随机临床试验的事后实证分析
Br J Clin Pharmacol. 2015 Apr;79(4):660-8. doi: 10.1111/bcp.12531.
3
Remote source document verification in two national clinical trials networks: a pilot study.两个国家临床试验网络中的远程源文件验证:一项试点研究。
PLoS One. 2013 Dec 5;8(12):e81890. doi: 10.1371/journal.pone.0081890. eCollection 2013.
4
The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature.临床试验监测方法对数据完整性和成本的影响——当前文献综述
Eur J Clin Pharmacol. 2016 Apr;72(4):399-412. doi: 10.1007/s00228-015-2004-y. Epub 2016 Jan 4.
5
Extended Risk-Based Monitoring Model, On-Demand Query-Driven Source Data Verification, and Their Economic Impact on Clinical Trial Operations.基于风险的扩展监测模型、按需查询驱动的源数据验证及其对临床试验运营的经济影响。
Ther Innov Regul Sci. 2016 Jan;50(1):115-122. doi: 10.1177/2168479015596020.
6
Impact of monitoring approaches on data quality in clinical trials.监测方法对临床试验数据质量的影响。
Br J Clin Pharmacol. 2023 Jun;89(6):1756-1766. doi: 10.1111/bcp.15615. Epub 2023 Jan 3.
7
Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system.在 TEMPER 研究中实施监测触发和触发与对照部位的匹配:触发监测管理系统的描述和评估。
Trials. 2019 Apr 17;20(1):227. doi: 10.1186/s13063-019-3301-z.
8
Clinical trial monitoring effectiveness: Remote risk-based monitoring versus on-site monitoring with 100% source data verification.临床试验监测效果:基于风险的远程监测与 100%源数据验证的现场监测。
Clin Trials. 2021 Apr;18(2):158-167. doi: 10.1177/1740774520971254. Epub 2020 Dec 1.
9
Efficient Source Data Verification Using Statistical Acceptance Sampling: A Simulation Study.使用统计验收抽样进行高效源数据验证:一项模拟研究。
Ther Innov Regul Sci. 2016 Jan;50(1):82-90. doi: 10.1177/2168479015602042.
10
The value of source data verification in a cancer clinical trial.癌症临床试验中源数据核实的价值。
PLoS One. 2012;7(12):e51623. doi: 10.1371/journal.pone.0051623. Epub 2012 Dec 12.

引用本文的文献

1
Source Data Verification (SDV) quality in clinical research: A scoping review.临床研究中的源数据核查(SDV)质量:一项范围综述
J Clin Transl Sci. 2024 May 21;8(1):e101. doi: 10.1017/cts.2024.551. eCollection 2024.
2
Development and Initial Implementation of a Clinical Monitoring Strategy in a Non-regulated Trial: a research note from the ReStOre II Trial.非注册试验中临床监测策略的制定与初步实施:来自ReStOre II试验的研究报告
HRB Open Res. 2024 Oct 18;6:46. doi: 10.12688/hrbopenres.13763.2. eCollection 2023.
3
A risk-based monitoring approach to source data monitoring and documenting monitoring findings.基于风险的源数据监测方法及监测结果记录方法。
Contemp Clin Trials. 2024 Aug;143:107581. doi: 10.1016/j.cct.2024.107581. Epub 2024 May 27.
4
Monitoring metrics over time: Why clinical trialists need to systematically collect site performance metrics.随时间监测指标:为何临床试验人员需要系统地收集研究点绩效指标。
Res Methods Med Health Sci. 2023 Sep;4(4):124-135. doi: 10.1177/26320843221147855. Epub 2022 Dec 21.
5
Monitoring strategies for clinical intervention studies.临床干预研究的监测策略。
Cochrane Database Syst Rev. 2021 Dec 8;12(12):MR000051. doi: 10.1002/14651858.MR000051.pub2.
6
Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic.监测进展包括同意书:从COVID-19试验及疫情期间在英国癌症研究中心注册的临床试验单位开展的其他试验中吸取经验教训。
Trials. 2021 Apr 14;22(1):279. doi: 10.1186/s13063-021-05225-5.
7
Using systematic data categorisation to quantify the types of data collected in clinical trials: the DataCat project.使用系统的数据分类方法来量化临床试验中收集的数据类型:DataCat 项目。
Trials. 2020 Jun 16;21(1):535. doi: 10.1186/s13063-020-04388-x.

本文引用的文献

1
Evaluating Source Data Verification as a Quality Control Measure in Clinical Trials.评估源数据核查作为临床试验中的一种质量控制措施
Ther Innov Regul Sci. 2014 Nov;48(6):671-680. doi: 10.1177/2168479014554400.
2
Risk-Based Monitoring: A Closer Statistical Look at Source Document Verification, Queries, Study Size Effects, and Data Quality.基于风险的监测:对源文件核查、质疑、研究规模效应和数据质量进行更深入的统计学审视
Ther Innov Regul Sci. 2015 Nov;49(6):903-910. doi: 10.1177/2168479015586001.
3
Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study.随机对照试验的触发或常规现场监测访问:前瞻性、配对研究 TEMPER 的结果。
Clin Trials. 2018 Dec;15(6):600-609. doi: 10.1177/1740774518793379. Epub 2018 Aug 22.
4
Assessing data quality and the variability of source data verification auditing methods in clinical research settings.评估临床研究环境中数据质量和源数据核查审核方法的可变性。
J Biomed Inform. 2018 Jul;83:25-32. doi: 10.1016/j.jbi.2018.05.010. Epub 2018 May 19.
5
Exploring Data Quality Management within Clinical Trials.探索临床试验中的数据质量管理。
Appl Clin Inform. 2018 Jan;9(1):72-81. doi: 10.1055/s-0037-1621702. Epub 2018 Jan 31.
6
Risk-adapted monitoring is not inferior to extensive on-site monitoring: Results of the ADAMON cluster-randomised study.风险适应性监测不劣于广泛的现场监测:ADAMON 整群随机研究结果
Clin Trials. 2017 Dec;14(6):584-596. doi: 10.1177/1740774517724165. Epub 2017 Aug 8.
7
Risk based monitoring (RBM) tools for clinical trials: A systematic review.用于临床试验的基于风险的监测(RBM)工具:一项系统评价。
Contemp Clin Trials. 2016 Nov;51:15-27. doi: 10.1016/j.cct.2016.09.003. Epub 2016 Sep 15.
8
Effect of a Perioperative Nutritional Supplementation with Oral Impact® in Patients undergoing Hepatic Surgery for Liver Cancer: A Prospective, Placebo-Controlled, Randomized, Double-Blind Study.围手术期口服Impact®营养补充对肝癌肝切除患者的影响:一项前瞻性、安慰剂对照、随机、双盲研究
Nutr Cancer. 2016;68(3):464-72. doi: 10.1080/01635581.2016.1153670. Epub 2016 Mar 23.
9
Key cost drivers of pharmaceutical clinical trials in the United States.美国药物临床试验的关键成本驱动因素。
Clin Trials. 2016 Apr;13(2):117-26. doi: 10.1177/1740774515625964. Epub 2016 Feb 8.
10
The impact of clinical trial monitoring approaches on data integrity and cost--a review of current literature.临床试验监测方法对数据完整性和成本的影响——当前文献综述
Eur J Clin Pharmacol. 2016 Apr;72(4):399-412. doi: 10.1007/s00228-015-2004-y. Epub 2016 Jan 4.